Business Development
Proactive Health Services
Full lifecycle services including chronic disease management, sleep management, innovative rehabilitation, public health services, etc., with successful cases such as early cancer screening, cardiovascular and cerebrovascular disease warning, CGM and other health monitoring scenarios, personalized diet/exercise recommendations, remote follow-up services, etc.
More
Diagnostic Testing Services for Medical Institution Alliances

Yunkang provides solutions to member hospitals in medical institution alliances for building up and managing their diagnostic centers. The on-site diagnostic center is normally located at the lead hospital. Member hospitals within the same medical institution alliance may also use the diagnostic capacities of the center, as they will also deliver their test samples to the diagnostic center for testing. Therefore, our diagnostic testing services for medical institution alliances assist hospitals to better manage their diagnostic operation by centralizing and utilizing their resources to enhance the diagnostic capacities of the whole medical institution alliance.

 

We Provide Comprehensive Solutions for Medical Institution Alliances
Diagnostic Outsourcing Services

Yunkang offers diagnostic outsourcing services to hospitals, other medical institutions and corporations at various levels. Facing the high volume of patient samples, under the premise of time- and cost-consuming testings performed by the hospitals, Yunkang provides a wide range of medical testing and clinical diagnostic services, including nucleic acid testing, genetic testing and diagnostic testing involving NGS technologies.

  • Pathology tests
  • Infectious disease diagnostic tests
  • Genetic disease diagnostic tests
  • Routine diagnostic tests
Pathology tests

Pathology tests primarily serve to identify and characterize the nature of tumors. According to Frost & Sullivan, the number of new confirmed cancer cases in China rose from 4.5 million in 2019 to 5.0 million in 2024, with a compound annual growth rate (CAGR) of 2.1%. Fueled by demographic shifts and environmental factors, the number of new cancer cases is projected to reach 5.7 million by 2032. Pathology tests are indispensable for clinicians to accurately diagnose the pathological profile of each patient, enabling the delivery of timely, specialized, and effective treatment protocols.

Infectious disease diagnostic tests

With the growing awareness of infectious diseases, Yunkang has gradually built up our service offerings for over 20 categories of infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus and nucleic acid tests for respiratory pathogens (including COVID-19 virus), among others.

Genetic disease diagnostic tests

In the field of genetic disease diagnostic testing, Yunkang can offer genetic screening tests at pre-pregnancy, pregnancy and new-born stages, aiming to help hospitals establish genetic pathology data for each patient so that they can design the most suitable treatment plan for the patient. It can even allow mothers to detect and prevent infectious disease and hereditary birth defects at pre-pregnancy and pregnancy stages, beneficial to prenatal and postnatal care.

Routine diagnostic tests

In addition, Yunkang provides certain routine diagnostic tests for chronic kidney disease, blood disease, autoimmune disease, endocrine metabolism disease and other diseases.

Copyright 2023 Yunkang Group Limited. All rights reserved. 粤ICP备12059545号-6 Privacy Policy | Disclaimers 网站建设技术支持:唯引互动